Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
3 clinical trials · Sponsor
◉ Watch Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors (NCT07156253) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2025-08-26 |
| Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors (NCT07088588) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2025-07-31 |
| Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors (NCT06666270) | Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd | 2024-11-21 |
Track Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.